Pulmonary arterial hypertension is caused by narrowing of the blood vessels in the lungs. Learn how it happens, including ...

if needed—on PAH, one of the leading causes of death in SSc. Their study prospectively analyzed 49 consecutive patients with SSc-associated PAH at a single pulmonary vascular center who received ...

Data show people with pulmonary arterial hypertension tend to stay in the hospital longer and have higher medical bills.

PH is defined as high lung blood pressure with various underlying causes. In comparison, PAH is a rare and gradually worsening condition in which the blood pressure in the pulmonary arteries ...

A larger diameter of the main pulmonary artery predicts poorer outcomes in pulmonary arterial hypertension (PAH) patients, a ...

You have full access to this article via your institution. Pulmonary arterial hypertension (PAH) is a chronic progressive disease characterized by endothelial cell (EC) dysfunction, substantial ...

Corsair Pharma is planning a Phase 1 clinical trial of its treprostinil skin patch as a treatment for pulmonary arterial hypertension (PAH).

Corsair Pharma Announces Successful Completion of Preclinical Program for Its Treprostinil Prodrug Transdermal System ...